New Scientist on MSN18h
GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditionsThe benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
A gut microbe could naturally regulate sugar cravings and blood sugar levels, offering a promising alternative to drugs like ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...
News Medical on MSN4h
GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesityGlucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been ...
Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making ...
Researchers took drugs currently used to treat type 2 diabetes and obesity and looked into how they affect 175 conditions.
A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues, including ...
It lowers blood pressure and cholesterol and sends 'fullness' signals to the brain, like a weight-loss drug. Here are simple ...
Commonly used diabetes drugs could lower the risk of cardiometabolic conditions but heighten the risk of gastrointestinal and ...
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback